Cited by 495Antifungal resistance and susceptibilityFungal and yeast genetics researchFungal Infections and Studies

Laboratory diagnosis of invasive aspergillosis

Open access
Hope, WW, Walsh, TJ, Denning, DW·2005·The Lancet Infectious Diseases

Abstract

Invasive aspergillosis occurs in a wide range of clinical scenarios, is protean in its manifestations, and is still associated with an unacceptably high mortality rate. Early diagnosis is critical to a favourable outcome, but is difficult to achieve with current methods. Deep tissue diagnostic specimens are often difficult to obtain from critically ill patients. Newer antifungal agents exhibit differential mould activity, thus increasing the importance of establishing a specific diagnosis of invasive aspergillosis. For these reasons, a range of alternate diagnostic strategies have been investigated. Most investigative efforts have focused on molecular and serological diagnostic techniques. The detection of metabolites produced by Aspergillus spp and a range of aspergillus-specific antibodies represent additional, but relatively underused, diagnostic avenues. The detection of galactomannan has been incorporated into diagnostic criteria for invasive aspergillosis, reflecting an increased understanding of the performance, utility, and limitations of this technique. Measurement of (1,3)-beta-D glucan in blood may be useful as a preliminary screening tool for invasive aspergillosis, despite the fact that this antigen can be detected in a number of other fungi. There have been extensive efforts directed toward the detection of Aspergillus spp DNA, but a lack of technical standardisation and relatively poor understanding of DNA release and kinetics continues to hamper the broad applicability of this technique. This review considers the application, utility, and limitations of the currently available and investigational diagnostic modalities for invasive aspergillosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(05)70238-3

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 137 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. Review
  2. Rath PM, Ansorg R. Identification of medically important Aspergillus species by single strand conformational polymorphism (SSCP) of the PCR-amplified intergenic spacer region. Mycoses 2000; 43: 381-86. 104

Cited by

Sorted by citations

Authors
Hope, W., Walsh, T., & Denning, D.
Affiliations
National Institutes of Health (US)
Venue
The Lancet Infectious Diseases
Publisher
Elsevier BV
Published
2005-10
Volume
5
Issue
10
Pages
609-622
ISSN
1473-3099 (ISSN-L)
OpenAlex
W2066421491
Cited by
495
References
137
Citations by year
2026: 9 · 2025: 10 · 2024: 12 · 2023: 12 · 2022: 15 · 2021: 13 · 2020: 9 · 2019: 21 · 2018: 15 · 2017: 23 · 2016: 30 · 2015: 36 · 2014: 23 · 2013: 30 · 2012: 33
FWCI
4.42
Type
journal article
Language
en
Locations
  • The Lancet Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
Keywords
invasive aspergillosis, Aspergillus, laboratory diagnosis, galactomannan, β-1,3-glucan, molecular diagnosis, serological diagnosis, fungal DNA detection, critically ill patients
MeSH terms
Antibodies, Fungal, Aspergillosis, Aspergillus, DNA, Fungal, Galactose, Humans, Mannans, Clinical Laboratory Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review